Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Richeldi

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
European Review for Medical and Pharmacological Sciences|August 1, 2019
Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapyF Varone, G Gibiino, A Gasbarrini, et al.
The Cochrane Database of Systematic Reviews|August 15, 2003
Corticosteroids for idiopathic pulmonary fibrosisL Richeldi, H R Davies, G Ferrara, et al.
Thorax|May 22, 2001
Analysis of sputum in COPDP Maestrelli, L Richeldi, M Moretti, et al.
The Indian Journal of Tuberculosis|August 23, 2020
From pulmonary susceptible tuberculosis to extensively drug resistant tuberculosis: An interesting case report of a young Indian girlE Intini, G Kishore, Z F Udwadia, et al.
Expert Review of Respiratory Medicine|April 2, 2023
Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approachAlessia Comes, Giacomo Sgalla, Simone Ielo, et al.
Sarcoidosis|September 1, 1993
Role of the HLA-DP gene in susceptibility to lung granulomasC Saltini, R Sorrentino, L Richeldi, et al.
Journal of Viral Hepatitis|April 14, 2010
The complex interrelationships between chronic lung and liver disease: a reviewP Spagnolo, S Zeuzem, L Richeldi, et al.
The European Respiratory Journal|January 7, 1999
Immunogenetic basis of environmental lung disease: lessons from the berylliosis modelC Saltini, M Amicosante, A Franchi, et al.
The Cochrane Database of Systematic Reviews|March 1, 2002
Macrolides for chronic asthmaL Richeldi, G Ferrara, L M Fabbri, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|December 8, 2009
Endogenous blood maximal interferon-gamma production may predict response to interferon-gamma 1beta treatment in patients with idiopathic pulmonary fibrosisF Luppi, M Losi, R D'Amico, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
European Review for Medical and Pharmacological Sciences|August 1, 2019
Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapyF Varone, G Gibiino, A Gasbarrini, et al.
The Cochrane Database of Systematic Reviews|August 15, 2003
Corticosteroids for idiopathic pulmonary fibrosisL Richeldi, H R Davies, G Ferrara, et al.
Thorax|May 22, 2001
Analysis of sputum in COPDP Maestrelli, L Richeldi, M Moretti, et al.
The Indian Journal of Tuberculosis|August 23, 2020
From pulmonary susceptible tuberculosis to extensively drug resistant tuberculosis: An interesting case report of a young Indian girlE Intini, G Kishore, Z F Udwadia, et al.
Expert Review of Respiratory Medicine|April 2, 2023
Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approachAlessia Comes, Giacomo Sgalla, Simone Ielo, et al.
Sarcoidosis|September 1, 1993
Role of the HLA-DP gene in susceptibility to lung granulomasC Saltini, R Sorrentino, L Richeldi, et al.
Journal of Viral Hepatitis|April 14, 2010
The complex interrelationships between chronic lung and liver disease: a reviewP Spagnolo, S Zeuzem, L Richeldi, et al.
The European Respiratory Journal|January 7, 1999
Immunogenetic basis of environmental lung disease: lessons from the berylliosis modelC Saltini, M Amicosante, A Franchi, et al.
The Cochrane Database of Systematic Reviews|March 1, 2002
Macrolides for chronic asthmaL Richeldi, G Ferrara, L M Fabbri, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|December 8, 2009
Endogenous blood maximal interferon-gamma production may predict response to interferon-gamma 1beta treatment in patients with idiopathic pulmonary fibrosisF Luppi, M Losi, R D'Amico, et al.
Pageof 6